Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- OBD.LSE
- Price
- 0.26
- Stock movement up
- +- (0.00%)
- Company name
- Oxford Biodynamics PLC
- Exchange
- (LSE ,
- Currency
- GBX )
- Sector
- Healthcare >Diagnostics & Research
- Market cap
- 11.16M
- Ent value
- 14.27M
- Price/Sales
- 7.37
- Price/Book
- 1.88
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- 8.33%
- 1 year return
- -78.33%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-12-12
DIVIDENDS
OBD.LSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 7.37 |
| Price to Book | 1.88 |
| EV to Sales | 9.43 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 4.29B |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | -0.00 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 4.26M |
| Net receivables | 2.10M |
| Total current assets | 6.65M |
| Goodwill | 0.00 |
| Intangible assets | 1.44M |
| Property, plant and equipment | 10.46M |
| Total assets | 13.30M |
| Accounts payable | 1.72M |
| Short/Current long term debt | 5.14M |
| Total current liabilities | 2.57M |
| Total liabilities | 7.37M |
| Shareholder's equity | 5.93M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.26 |
| Daily high | 0.26 |
| Daily low | 0.25 |
| Daily Volume | 15.9M |
| All-time high | 3.78 |
| 1y analyst estimate | 175.00 |
| Beta | -0.49 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| OBD.LSE | S&P500 | |
| Current price drop from All-time high | -93.12% | -1.08% |
| Highest price drop | -93.39% | -19.00% |
| Date of highest drop | 2 Dec 2025 | 8 Apr 2025 |
| Avg drop from high | -83.10% | -2.64% |
| Avg time to new high | 150 days | 6 days |
| Max time to new high | 299 days | 89 days |
COMPANY DETAILS
Marketcap
11.16M
Marketcap category
Small-cap
Description
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and the United Kingdom. The company provides EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation, and monitoring of 3D genomic biomarkers to diagnose patients. Its products include EpiSwitch Prostate Screening Test (PSE), a prostate cancer screening test; EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a blood test for predicting therapeutic response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling. The company was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.
Employees
44
Investor relations
-
SEC filings
CEO
Country
UK
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found